IPad 2




iPad 2 is a tablet computer developed by Apple Inc. It is the second generation of the iPad line and was announced on March 2, 2011, by then-CEO Steve Jobs. The iPad 2 was released in the United States on March 11, 2011, and later rolled out to other countries. It built upon the original iPad's features with a slimmer design, faster processor, and improved graphics capabilities.
Design and Features[edit]
The iPad 2 features a 9.7-inch (diagonal) LED-backlit Multi-Touch display with IPS technology, offering a resolution of 1024x768 pixels at 132 pixels per inch (ppi). It is powered by a dual-core Apple A5 processor, enhancing its performance over its predecessor. The device comes in two variants: Wi-Fi only and Wi-Fi + 3G, with the latter offering cellular connectivity. It introduced cameras to the iPad line, featuring a front-facing VGA camera for FaceTime and video calling, and a rear-facing camera capable of recording 720p video.
The iPad 2's design is notably thinner and lighter than the original iPad. It measures 0.34 inch (8.8 mm) in thickness and weighs 1.33 pounds (601 grams) for the Wi-Fi model and 1.35 pounds (613 grams) for the Wi-Fi + 3G model. The device was available in black and white color options.
Software[edit]
The iPad 2 originally shipped with iOS 4.3, introducing several new features, including AirPlay mirroring and improvements to the Safari web browser. Over its lifespan, the iPad 2 received multiple iOS updates, with its final supported version being iOS 9.3.5. This extended software support period is notable, as it allowed the iPad 2 to receive updates for over five years after its release.
Reception[edit]
Upon its release, the iPad 2 received widespread acclaim for its design, improved performance, and battery life, maintaining Apple's position in the tablet market. Critics praised its thin profile and the addition of cameras, though some noted that the cameras' quality was not as high as expected.
Legacy[edit]
The iPad 2 is considered a pivotal device in the tablet industry, setting standards for future devices in terms of design and functionality. It remained in production until March 2014, making it one of the longest-produced iPads, which is a testament to its enduring popularity.
See Also[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


